Skip Navigation

Research

NEWS

RESEARCH

A photo of Bentley.
Research

New Drug Dramatically Improves Survival for Children with Common Type of Leukemia

December 09, 2024

A University of Oklahoma Health Sciences clinical trial studying whether a drug called blinatumomab, when given in conjunction with chemotherapy, would improve patients’ survival without the cancer returning will now be standard practice to give in combination with chemotherapy to children with standard-risk B-ALL, the most common childhood cancer.

Hakeem Shakir.
Research

OU Researcher Contributes to Study Published in Prestigious New England Journal of Medicine

November 26, 2024

OU College of Medicine is one of 39 trial sites nationwide that found embolization plus surgery reduces risk of brain bleed recurrence.

All Research Articles